Publicaciones en las que colabora con José A. Obeso Inchausti (188)

2024

  1. Calbindin and Girk2/Aldh1a1 define resilient vs vulnerable dopaminergic neurons in a primate Parkinson’s disease model

    npj Parkinson's Disease, Vol. 10, Núm. 1

  2. Subspace corrected relevance learning with application in neuroimaging

    Artificial Intelligence in Medicine, Vol. 149

  3. The causal role of the subthalamic nucleus in the inhibitory network

    Annals of the New York Academy of Sciences, Vol. 1538, Núm. 1, pp. 117-128

2022

  1. Cerebral metabolic pattern associated with progressive parkinsonism in non-human primates reveals early cortical hypometabolism

    Neurobiology of Disease, Vol. 167

  2. Home-based transcranial static magnetic field stimulation of the motor cortex for treating levodopa-induced dyskinesias in Parkinson's disease: A randomized controlled trial

    Brain Stimulation

  3. The motor inhibitory network in patients with asymmetrical Parkinson’s disease: An fMRI study

    Brain Imaging and Behavior, Vol. 16, Núm. 3, pp. 1349-1361

2021

  1. Bilateral staged magnetic resonance-guided focused ultrasound thalamotomy for the treatment of essential tremor: A case series study

    Journal of Neurology, Neurosurgery and Psychiatry, Vol. 92, Núm. 9, pp. 927-931

2020

  1. Abnormal pattern of brain glucose metabolism in Parkinson’s disease: replication in three European cohorts

    European Journal of Nuclear Medicine and Molecular Imaging, Vol. 47, Núm. 2, pp. 437-450

2019

  1. Parkinson’s disease with mild cognitive impairment: severe cortical thinning antedates dementia

    Brain Imaging and Behavior, Vol. 13, Núm. 1, pp. 180-188

2018

  1. Machine learning based analysis of FDG-PET image data for the diagnosis of neurodegenerative diseases

    Frontiers in Artificial Intelligence and Applications

  2. Pooled-DNA target sequencing of Parkinson genes reveals novel phenotypic associations in Spanish population

    Neurobiology of Aging, Vol. 70, pp. 325.e1-325.e5

  3. Subthalamotomy for Parkinson's disease: Clinical outcome and topography of lesions

    Journal of Neurology, Neurosurgery and Psychiatry, Vol. 89, Núm. 6, pp. 572-578

2017

  1. Impulse control disorders and levodopa-induced dyskinesias in Parkinson's disease: an update

    The Lancet Neurology, Vol. 16, Núm. 3, pp. 238-250

2016

  1. Significance of visual hallucinations and cerebral hypometabolism in the risk of dementia in Parkinson's disease patients with mild cognitive impairment

    Human Brain Mapping, Vol. 37, Núm. 3, pp. 968-977

  2. Stimulation sites in the subthalamic nucleus and clinical improvement in Parkinson's disease: A new approach for active contact localization

    Journal of Neurosurgery, Vol. 125, Núm. 5, pp. 1068-1079

2015

  1. Editorial: Parkinson’s disease: Cell vulnerability and disease progression

    Frontiers in Neuroanatomy

  2. Monoaminergic PET imaging and histopathological correlation in unilateral and bilateral 6-hydroxydopamine lesioned rat models of Parkinson's disease: A longitudinal in-vivo study

    Neurobiology of Disease, Vol. 77, pp. 165-172

2014

  1. Grey matter hypometabolism and atrophy in Parkinson's disease with cognitive impairment: A two-step process

    Brain, Vol. 137, Núm. 8, pp. 2356-2367

  2. High beta activity in the subthalamic nucleus and freezing of gait in Parkinson's disease

    Neurobiology of Disease, Vol. 64, pp. 60-65

  3. Longitudinal assessment of the pattern of cognitive decline in non-demented patients with advanced Parkinson's disease

    Journal of Parkinson's Disease, Vol. 4, Núm. 4, pp. 677-686